NEW HAY FEVER TRIAL | 17 GP and allergy clinics have partnered with @NACEresearch to launch an 🇦🇺-wide trial to help address our most common #allergy 🤧
The ARISE Trial is seeking 14-29 year olds with #allergicrhinitis to take part. Learn more ➡️ https://t.co/YS4YTclWQ4
🎉Congrats to @Natalie31583583✨. 📢Her first PhD paper is published in @jacionline. 📄Reduced levels of "POS ceramides" (skin lipids) were associated with the development of #atopicdermatitis. 👉🏼Read here: https://t.co/OVgMmb2EiQ 📡In the Media: https://t.co/Ec8I7U2FHX
Good news! My article received enough citations to be a Top Cited Article published by Clinical and Experimental Allergy in 2023. Read it here https://t.co/aAMYVYN5WP #TopCitedArticle@wileyinresearch
#ASCIA2024 | Red Imported Fire Ants are spreading. @D_J_Lopez presented the #allergy risks if RIFA are not contained in Australia.
Diego and other NACE and @AAAaust experts addressed a Senate inquiry in March into the cost and impact of RIFA.
More ➡️ https://t.co/2oMFsGcxBe
🔎Our latest research, led at #MCRI by Prof Mimi Tang shows that remission is the best treatment outcome for #children with 🥜#allergy. @mimitang64
Watch Prof Tang explain our latest findings here:
https://t.co/Q2r1eMjblf
Longitudinal peanut and Ara h 2 specific-IgE, -IgG4, and -IgG4/-IgE ratios are associated with the natural resolution of peanut allergy in childhood. First author: Kayla M. Parker; corresponding author: Rachel Peters
Read the article here: https://t.co/cc9qZpVONk
34% of infants with challenge-confirmed peanut allergy at age 1 year outgrew their peanut allergy. Resolution of peanut allergy between ages 6 and 10 years was rare. Peanut and Ara h 2 sIgE, sIgE/tIgE, sIgG4, and sIgG4/sIgE measured at age 1 year had poor to moderate value in determining whether infants with peanut allergy outgrow or have persistent disease by 10-years-of-age. Peanut allergy resolution was associated with decreasing Ara h 2 sIgE, increasing sIgG4 and increasing sIgG4/sIgE to both peanut and Ara h 2 from 1 to 10-years-of-age.
#Allergy_journal
Read more articles published in #Allergy on #foodallergy here: https://t.co/3zmbAv02of
🔹#RespirologyCaseReports
Welcome our new Associate Editor specialist for Clinical Trial Protocols Prof. Adrian Lowe, the University of Melbourne, Allergy and Lung Health Unit.
What can health professionals do about climate change? The answer is a lot!
See our brief summary in plain language recently published by MJA Insight+ @YumingGuo007@Monash_SPHPM@theMJA@VicHealth
https://t.co/dYCUaZB1i4
Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease - Dharmage - 2024 - Respirology - Wiley Online Library https://t.co/EMa2WIsrAA